11-19-2018 03:43 PM CET - Health & Medicine
Print

Global Biomarkers Market Analysis In 2018 to 2025 With - Bio-Rad Laboratories, QIAGEN, Merck, PerkinElmer, Inc. , Singulex, EKF Diagnostics, MESO SCALE DIAGNOSTICS, LLC., Signosis Inc, Cisbio

Press release from: Data Bridge Market Research
Biomarkers
Biomarkers


The Global Biomarkers Market is expected to reach USD 85,927.95 million by 2024, from USD 28,091.78 million and growing at a CAGR of 15.1% in forecast period. The factors such as increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market.

Get Sample on Global Market Information: databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global biomarker market is growing with the increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market. Global biomarkers market is dominated by Bio-Rad Laboratories, Inc., followed by Perkin Elmer, Inc. and Qiagen. Other Players Are

· Merck & Co. Inc

· Enzo Biochem, Inc

· Ekf Diagnostics

· Meso Scale Diagnostics, Llc

· Singulex, Inc

· Signosis, Inc

· Cisbio Bioassays

On the other hand, high capital investment may hinder the growth of the market. The biomarker market in the Global region is leading in North America.

· Consumables segment is expected to dominate the Global biomarkers market.

· The biomarkers market in the Global region is leading in North America, Europe, Asia-Pacific accounts for the highest market share in this region.

Get TOC of Full Report: databridgemarketresearch.com/toc/?dbmr=global-biomarkers-...

Segmentation

· The global biomarker market is segmented on the basis of product type, technology, application and indication.

· The global biomarkers market is segmented based on product type into three notable segments;

• Consumables
• Services
Software

· consumables segment is expected to dominate the global biomarkers market with 58.6% market share and is expected to reach USD 51,156.05 million by 2024, with the highest CAGR of 15.4% in the forecast period.

· On the basis of technology, global biomarker market is segmented into three notable segments;

• Safety biomarkers
• Efficacy biomarkers
• Validation biomarkers

· safety biomarkers is expected to dominate the global biomarkers market with 47.8% market share and is expected to reach USD 41,933.30 million by 2024, with the highest CAGR of 15.4% in the forecast period.

· On the basis of application, global biomarker market is segmented into

• Diagnostics development,
• Drug discovery and development,
• Personalized medicine,
• Disease-risk assessment, and others.

· Diagnostic development is expected to dominate the market with the market share of 35.4% the market is expected to reach USD 29,148.7 million by 2024, growing at a CAGR of 14.4% in the forecast period to 2024. However, personalized medicine is expected to grow at the highest CAGR of 16.2% in the forecast period, and is expected to reach USD 19,520.5 million in 2024 from USD 5,901.5 million in 2016.

· The Global biomarkers market is segmented based on indication into four notable segments;

• Cancer
• Cardiovascular disorders
• Neurological disorders
• Immunological disorders, and others diseases

· In 2017, cancer is expected to dominate the global biomarkers market with 38.0% market share and is expected to reach USD 32,632.11 million by 2024, with a CAGR of 15.1% in the forecast period to 2024. However, cardiovascular disorders is expected to grow at the highest CAGR of 15.9% in the forecast period, and is expected to reach USD 25,063.53 million in 2024 from USD 7,736.13 million in 2016.


Want Full Report? Enquire Here: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization or Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
databridgemarketresearch.com

This release was published on openPR.
News-ID: 1382640 • Views: 228
More releasesMore releases

You can edit or delete your press release here: